Use of extended-release niacin in clinical practice

By Suryadevara Ramya S   Karas Richard H   Kuvin Jeffrey T  

Future Lipidology, Vol. 3, Iss. 1, 2008-02 ,pp. : 9-16

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers

By Zhao Qinying   Janssens Luc   Verhaeghe Tom   Brashear H. Robert   Truyen Luc  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1547-1554

Informa Healthcare

Access to resources Recommend Favorite

Steady‐state pharmacokinetics and bioavailability of immediate‐release and extended‐release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1101-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended‐Release Oxycodone Formulations with Abuse‐Deterrent Properties

By  

PAIN MEDICINE, Vol. 16, Iss. 11, 2015-11 ,pp. : 2142-2151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet® CR), and carbidopa‐levodopa‐entacapone (Stalevo®)

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 995-1003

John Wiley & Sons Inc

Access to resources Recommend Favorite